Tavares, Grasiele de Sousa VieiraMendonça, Débora Vasconcelos CostaMiyazaki, Carolina KeiLage, Daniela PagliaraSoyer, Tauane GonçalvesCarvalho, Lívia MendesOttoni, Flaviano MeloDias, Daniel SilvaRibeiro, Patrícia Aparecida FernandesAntinarelli, Luciana Maria RibeiroRibeiro, Fernanda LudolfDuarte, Mariana CostaCoimbra, Elaine SoaresChávez Fumagalli, Miguel AngelRoatt, Bruno MendesSouza, Daniel MenezesBarichello, José MarioAlves, Ricardo JoséCoelho, Eduardo Antônio Ferraz2019-04-032019-04-032019TAVARES, G. de S. V. et al. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection. Parasitology International, v. 68, n. 1, p. 63-72, fev. 2019. Disponível em: <https://www.sciencedirect.com/science/article/pii/S1383576918303751?via%3Dihub>. Acesso em: 22 fev. 2019.13835769http://www.repositorio.ufop.br/handle/123456789/10928Clioquinol (5-chloro-7-iodoquinolin-8-ol or ICHQ) was recently showed to presents an in vitro effective antileishmanial action, causing changes in membrane permeability, mitochondrial functionality, and parasite morphology. In the present study, ICHQ was incorporated into a Poloxamer 407-based polymeric micelles system (ICHQ/M), and its antileishmanial activity was in vivo evaluated in L. amazonensis-infected BALB/c mice. Amphotericin B (AmpB) and its liposomal formulation (Ambisome®) were used as controls. Parasitological and immunological evaluations were performed 30 days after the treatment. Results indicated more significant reductions in the average lesion diameter and parasite burden in ICHQ or ICHQ/M-treated mice, which were associated with the development of a polarized Th1 immune response, based on production of high levels of IFN-γ, IL-12, TNF-α, GM-CSF, and antileishmanial IgG2a antibody. Control groups´ mice produced high levels of IL-4, IL-10, and IgG1 isotype antibody. No organic toxicity was found by using ICHQ or ICHQ/M to treat the animals, although those receiving AmpB and Ambisome® have presented higher levels of renal and hepatic damage markers. In conclusion, results suggested that the ICHQ/M composition can be considered as an antileishmanial candidate to be tested against human leishmaniasis.en-USrestritoVisceral leishmaniasis5-chloro-7-iodoquinolin-8-olToxicityDelivery systemsArtigo publicado em periodicohttps://www.sciencedirect.com/science/article/pii/S1383576918303751